PL337507A1 - Novel derivatives of beta-amino and beta-azidocarboxylic acids, their production and application as antagonists of endothelin receptors - Google Patents
Novel derivatives of beta-amino and beta-azidocarboxylic acids, their production and application as antagonists of endothelin receptorsInfo
- Publication number
- PL337507A1 PL337507A1 PL98337507A PL33750798A PL337507A1 PL 337507 A1 PL337507 A1 PL 337507A1 PL 98337507 A PL98337507 A PL 98337507A PL 33750798 A PL33750798 A PL 33750798A PL 337507 A1 PL337507 A1 PL 337507A1
- Authority
- PL
- Poland
- Prior art keywords
- beta
- antagonists
- amino
- production
- application
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/08—Drugs for disorders of the urinary system of the prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/04—Antineoplastic agents specific for metastasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C247/00—Compounds containing azido groups
- C07C247/02—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton
- C07C247/12—Compounds containing azido groups with azido groups bound to acyclic carbon atoms of a carbon skeleton being further substituted by carboxyl groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/02—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings
- C07D237/06—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D237/10—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D237/14—Oxygen atoms
- C07D237/16—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/32—One oxygen, sulfur or nitrogen atom
- C07D239/34—One oxygen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
- C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
- C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
- C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
- C07D239/52—Two oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D251/00—Heterocyclic compounds containing 1,3,5-triazine rings
- C07D251/02—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings
- C07D251/12—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members
- C07D251/14—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom
- C07D251/22—Heterocyclic compounds containing 1,3,5-triazine rings not condensed with other rings having three double bonds between ring members or between ring members and non-ring members with hydrogen or carbon atoms directly attached to at least one ring carbon atom to two ring carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Urology & Nephrology (AREA)
- Pulmonology (AREA)
- Neurosurgery (AREA)
- Hematology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Hospice & Palliative Care (AREA)
- Diabetes (AREA)
- Neurology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE19726146A DE19726146A1 (en) | 1997-06-19 | 1997-06-19 | New ß-amino and ß-azidopcarboxylic acid derivatives, their preparation and use as endothelin receptor antagonists |
PCT/EP1998/003366 WO1998058916A1 (en) | 1997-06-19 | 1998-06-05 | NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS |
Publications (1)
Publication Number | Publication Date |
---|---|
PL337507A1 true PL337507A1 (en) | 2000-08-28 |
Family
ID=7833081
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL98337507A PL337507A1 (en) | 1997-06-19 | 1998-06-05 | Novel derivatives of beta-amino and beta-azidocarboxylic acids, their production and application as antagonists of endothelin receptors |
Country Status (22)
Country | Link |
---|---|
EP (1) | EP0994861A1 (en) |
JP (1) | JP2002504130A (en) |
KR (1) | KR20010013981A (en) |
CN (1) | CN1261352A (en) |
AR (1) | AR015893A1 (en) |
AU (1) | AU8213398A (en) |
BG (1) | BG104022A (en) |
BR (1) | BR9810182A (en) |
CA (1) | CA2294050A1 (en) |
CO (1) | CO4950605A1 (en) |
DE (1) | DE19726146A1 (en) |
HR (1) | HRP980331A2 (en) |
HU (1) | HUP0002714A3 (en) |
ID (1) | ID24346A (en) |
IL (1) | IL133104A0 (en) |
NO (1) | NO996268L (en) |
NZ (1) | NZ502319A (en) |
PL (1) | PL337507A1 (en) |
SK (1) | SK176299A3 (en) |
TR (1) | TR199903159T2 (en) |
WO (1) | WO1998058916A1 (en) |
ZA (1) | ZA985277B (en) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19806438A1 (en) * | 1998-02-17 | 1999-08-19 | Basf Ag | New pyrimidinyloxy-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiac insufficiency, restenosis, hypertension, kidney failure, asthma and prostate cancer |
DE19858779A1 (en) * | 1998-12-18 | 2000-06-21 | Basf Ag | New 3-acylamino-propionic acid and 3-sulfonylamino-propionic acid derivatives useful as endothelin receptor antagonists in treatment of e.g. cardiovascular and renal disorders, migraine and cancer |
DE19924892A1 (en) * | 1999-06-01 | 2000-12-07 | Basf Ag | New carboxylic acid derivatives with aryl-substituted nitrogen heterocycles, their production and use as endothelin receptor antagonists |
WO2002064573A1 (en) * | 2001-02-14 | 2002-08-22 | Abbott Gmbh & Co. Kg | Novel carboxylic acid derivatives containing alkyl substituted triazines, production of the same and use thereof as endothelin receptor antagonists |
EP1632821B1 (en) | 2004-09-01 | 2012-05-30 | Océ-Technologies B.V. | Intermediate transfer member with a cleaning member |
US7790770B2 (en) * | 2005-11-23 | 2010-09-07 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
EP2183223A2 (en) * | 2007-07-31 | 2010-05-12 | Gilead Colorado, Inc. | Metabolites and derivatives of ambrisentan |
CN109422664B (en) * | 2017-08-23 | 2022-02-18 | 中国科学院福建物质结构研究所 | Interferon regulator and its prepn and use |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5136060A (en) * | 1989-11-14 | 1992-08-04 | Florida State University | Method for preparation of taxol using an oxazinone |
DE4411225A1 (en) * | 1994-03-31 | 1995-10-05 | Basf Ag | Use of carboxylic acid derivatives as a drug |
DE19614533A1 (en) * | 1996-04-12 | 1997-10-16 | Basf Ag | New alpha-hydroxy acid derivatives, their production and use |
-
1997
- 1997-06-19 DE DE19726146A patent/DE19726146A1/en not_active Withdrawn
-
1998
- 1998-06-05 CA CA002294050A patent/CA2294050A1/en not_active Abandoned
- 1998-06-05 WO PCT/EP1998/003366 patent/WO1998058916A1/en not_active Application Discontinuation
- 1998-06-05 IL IL13310498A patent/IL133104A0/en unknown
- 1998-06-05 CN CN98806397A patent/CN1261352A/en active Pending
- 1998-06-05 EP EP98932123A patent/EP0994861A1/en not_active Withdrawn
- 1998-06-05 JP JP50366799A patent/JP2002504130A/en active Pending
- 1998-06-05 KR KR19997012007A patent/KR20010013981A/en not_active Application Discontinuation
- 1998-06-05 SK SK1762-99A patent/SK176299A3/en unknown
- 1998-06-05 NZ NZ502319A patent/NZ502319A/en unknown
- 1998-06-05 ID IDW991614A patent/ID24346A/en unknown
- 1998-06-05 PL PL98337507A patent/PL337507A1/en unknown
- 1998-06-05 TR TR1999/03159T patent/TR199903159T2/en unknown
- 1998-06-05 HU HU0002714A patent/HUP0002714A3/en unknown
- 1998-06-05 BR BR9810182-0A patent/BR9810182A/en not_active IP Right Cessation
- 1998-06-05 AU AU82133/98A patent/AU8213398A/en not_active Abandoned
- 1998-06-17 HR HR19726146.9A patent/HRP980331A2/en not_active Application Discontinuation
- 1998-06-17 AR ARP980102873A patent/AR015893A1/en unknown
- 1998-06-18 CO CO98034781A patent/CO4950605A1/en unknown
- 1998-06-18 ZA ZA9805277A patent/ZA985277B/en unknown
-
1999
- 1999-12-16 BG BG104022A patent/BG104022A/en unknown
- 1999-12-17 NO NO996268A patent/NO996268L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
ID24346A (en) | 2000-07-13 |
CN1261352A (en) | 2000-07-26 |
NO996268D0 (en) | 1999-12-17 |
AR015893A1 (en) | 2001-05-30 |
HRP980331A2 (en) | 1999-02-28 |
BG104022A (en) | 2001-04-30 |
IL133104A0 (en) | 2001-03-19 |
KR20010013981A (en) | 2001-02-26 |
TR199903159T2 (en) | 2000-07-21 |
CO4950605A1 (en) | 2000-09-01 |
DE19726146A1 (en) | 1998-12-24 |
JP2002504130A (en) | 2002-02-05 |
CA2294050A1 (en) | 1998-12-30 |
WO1998058916A1 (en) | 1998-12-30 |
HUP0002714A2 (en) | 2001-05-28 |
AU8213398A (en) | 1999-01-04 |
ZA985277B (en) | 1999-12-20 |
SK176299A3 (en) | 2000-06-12 |
EP0994861A1 (en) | 2000-04-26 |
NZ502319A (en) | 2002-03-01 |
NO996268L (en) | 1999-12-17 |
HUP0002714A3 (en) | 2001-07-30 |
BR9810182A (en) | 2000-08-08 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PL331998A1 (en) | Derivatives of azinyloxy-a nd phenyloxy-diaryl carboxylic acids, their production and application as mixed antagonists of endothelin et/et receptors | |
AU6267198A (en) | Amides as npy5 receptor antagonists | |
IL122464A0 (en) | N-heteroaryl-pyridinesulonamide derivatives and their use as endothelin antagonists | |
IL123581A0 (en) | Pyrimidine derivatives as 5HT2c- receptor antagonists | |
AU6144098A (en) | Amide derivatives as selective neuropeptide y receptor antagonists | |
HU9600256D0 (en) | Substituted diphenyl-sulfonamides, antagonists of endothelin | |
IL133433A0 (en) | Azetidinylpropylpiperidine derivatives, intermediates and use as tachykinin antagonists | |
PL342500A1 (en) | Derivatives of pyrolydin-3-carboxylic acid and their application as endothelin antagonists | |
HUP0203246A3 (en) | Process and intermediates for the preparation of imidazolidinone alpha v integrin antagonists | |
PL326081A1 (en) | Novel derivatives of amino acids, their production and application | |
PL339545A1 (en) | Rantes trimmed at its amino end as antagonists of chemokin | |
PL341114A1 (en) | Antagonists of thrombosin receptors | |
PL329241A1 (en) | Novel derivatives of alpha-hydroxycarboxylic acids, their production and application | |
HK1031808A1 (en) | Production of hydrolysate | |
ZA952461B (en) | Antagonists of endothelin receptors | |
PL337507A1 (en) | Novel derivatives of beta-amino and beta-azidocarboxylic acids, their production and application as antagonists of endothelin receptors | |
PL329238A1 (en) | Novel derivatives of alpha-hydroxycarboxylic acids, their production and application | |
PL340871A1 (en) | Novel derivatives of carboxylic with admidic side chains, method of obtaining them and application of such novel derivatives as antagonists of endothelin rceptors | |
PL334014A1 (en) | Heterocyclic derivatives of carboxylic acids, their preduction and application as antagonists of endothelin receptors | |
ID30484A (en) | DERUNAN 4-HETEROSICLICSULFONAMIDYL 6 METHODS 5 (2 PHENOXIC METHODS) 2 PYRIDYL-PYRIMIDINS, THEIR PRODUCTION AND USE AS ANTAGONISTS OF ENDOTELINE RECEPTORS | |
PL333079A1 (en) | Piparazinic derivatives as antagonists of neurokinin | |
ID24306A (en) | KUINOLIN-2 CARCOXICATE ACID DECREASE AND ITS USE AS AMITO EXITATORY AMINO ANTAGONISTS | |
PL338954A1 (en) | Novel derivatives of carboxylic acids, their production and application as mixed antagonists of endothelin et a/et b receptors | |
IL137038A0 (en) | 5-substituted pyrimidine-2-yloxy carboxylic acid derivatives, the production of the same and their utilization as endothelin antagonists | |
IL135461A0 (en) | NOVEL HETEROCYCLICALLY SUBSTITUTED α- HYDROXYCARBOXLIC ACID DERIVATIVES, METHOD FOR PRODUCING THE SAME AND THEIR USE AS ENDOTHELIN RECEPTOR ANTAGONISTS |